List of Tables
    Table 1. Gastric Antisecretory Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Gastric Antisecretory Drug Market Trends
    Table 3. Gastric Antisecretory Drug Market Drivers
    Table 4. Gastric Antisecretory Drug Market Challenges
    Table 5. Gastric Antisecretory Drug Market Restraints
    Table 6. Global Gastric Antisecretory Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Gastric Antisecretory Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Gastric Antisecretory Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Gastric Antisecretory Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Gastric Antisecretory Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Gastric Antisecretory Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Gastric Antisecretory Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Gastric Antisecretory Drug Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Gastric Antisecretory Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Gastric Antisecretory Drug Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Gastric Antisecretory Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Gastric Antisecretory Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Antisecretory Drug as of 2021)
    Table 18. Top Players of Gastric Antisecretory Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Gastric Antisecretory Drug Product Type
    Table 20. Date of International Manufacturers Enter into Gastric Antisecretory Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Gastric Antisecretory Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Gastric Antisecretory Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Gastric Antisecretory Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Gastric Antisecretory Drug Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Gastric Antisecretory Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Gastric Antisecretory Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Gastric Antisecretory Drug Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Gastric Antisecretory Drug Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Gastric Antisecretory Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Gastric Antisecretory Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Gastric Antisecretory Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Gastric Antisecretory Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Gastric Antisecretory Drug Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Gastric Antisecretory Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Gastric Antisecretory Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Gastric Antisecretory Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Gastric Antisecretory Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Gastric Antisecretory Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Gastric Antisecretory Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Gastric Antisecretory Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bayer Corporation Information
    Table 43. Bayer Description and Business Overview
    Table 44. Bayer Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Bayer Gastric Antisecretory Drug Product
    Table 46. Bayer Recent Development
    Table 47. Cadila Pharmaceuticals Corporation Information
    Table 48. Cadila Pharmaceuticals Description and Business Overview
    Table 49. Cadila Pharmaceuticals Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Cadila Pharmaceuticals Product
    Table 51. Cadila Pharmaceuticals Recent Development
    Table 52. AstraZeneca Corporation Information
    Table 53. AstraZeneca Description and Business Overview
    Table 54. AstraZeneca Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. AstraZeneca Product
    Table 56. AstraZeneca Recent Development
    Table 57. Jiangsu Aosaikang Corporation Information
    Table 58. Jiangsu Aosaikang Description and Business Overview
    Table 59. Jiangsu Aosaikang Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Jiangsu Aosaikang Product
    Table 61. Jiangsu Aosaikang Recent Development
    Table 62. Eisai Corporation Information
    Table 63. Eisai Description and Business Overview
    Table 64. Eisai Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Eisai Product
    Table 66. Eisai Recent Development
    Table 67. Pfizer Corporation Information
    Table 68. Pfizer Description and Business Overview
    Table 69. Pfizer Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Pfizer Product
    Table 71. Pfizer Recent Development
    Table 72. Altana Pharma Corporation Information
    Table 73. Altana Pharma Description and Business Overview
    Table 74. Altana Pharma Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Altana Pharma Product
    Table 76. Altana Pharma Recent Development
    Table 77. Takeda Corporation Information
    Table 78. Takeda Description and Business Overview
    Table 79. Takeda Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Takeda Product
    Table 81. Takeda Recent Development
    Table 82. NCPC Corporation Information
    Table 83. NCPC Description and Business Overview
    Table 84. NCPC Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. NCPC Product
    Table 86. NCPC Recent Development
    Table 87. Luoxin Corporation Information
    Table 88. Luoxin Description and Business Overview
    Table 89. Luoxin Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Luoxin Product
    Table 91. Luoxin Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Gastric Antisecretory Drug Customers List
    Table 95. Gastric Antisecretory Drug Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastric Antisecretory Drug Product Picture
    Figure 2. Global Gastric Antisecretory Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Gastric Antisecretory Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Gastric Antisecretory Drug Sales 2017-2028 (K Units)
    Figure 5. United States Gastric Antisecretory Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Gastric Antisecretory Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Gastric Antisecretory Drug Sales 2017-2028 (K Units)
    Figure 8. United States Gastric Antisecretory Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Gastric Antisecretory Drug Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Gastric Antisecretory Drug Report Years Considered
    Figure 11. Product Picture of H2-receptor Antagonists
    Figure 12. Product Picture of Gastric Proton Pump Inhibitors
    Figure 13. Product Picture of Others
    Figure 14. Global Gastric Antisecretory Drug Market Share by Type in 2022 & 2028
    Figure 15. Global Gastric Antisecretory Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Gastric Antisecretory Drug Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Gastric Antisecretory Drug Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Gastric Antisecretory Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Gastric Antisecretory Drug Price by Type (2017-2028) & (US$/Unit)
    Figure 20. United States Gastric Antisecretory Drug Market Share by Type in 2022 & 2028
    Figure 21. United States Gastric Antisecretory Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Gastric Antisecretory Drug Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Gastric Antisecretory Drug Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Gastric Antisecretory Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Gastric Antisecretory Drug Price by Type (2017-2028) & (US$/Unit)
    Figure 26. Product Picture of Dyspepsia
    Figure 27. Product Picture of Peptic Ulcer
    Figure 28. Product Picture of Gastroesophageal Reflux
    Figure 29. Product Picture of Others
    Figure 30. Global Gastric Antisecretory Drug Market Share by Application in 2022 & 2028
    Figure 31. Global Gastric Antisecretory Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Gastric Antisecretory Drug Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Gastric Antisecretory Drug Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Gastric Antisecretory Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Gastric Antisecretory Drug Price by Application (2017-2028) & (US$/Unit)
    Figure 36. United States Gastric Antisecretory Drug Market Share by Application in 2022 & 2028
    Figure 37. United States Gastric Antisecretory Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Gastric Antisecretory Drug Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Gastric Antisecretory Drug Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Gastric Antisecretory Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Gastric Antisecretory Drug Price by Application (2017-2028) & (US$/Unit)
    Figure 42. North America Gastric Antisecretory Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Gastric Antisecretory Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Gastric Antisecretory Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe Gastric Antisecretory Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Gastric Antisecretory Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific Gastric Antisecretory Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Gastric Antisecretory Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 66. Latin America Gastric Antisecretory Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Gastric Antisecretory Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 71. Middle East & Africa Gastric Antisecretory Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. UAE Gastric Antisecretory Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Gastric Antisecretory Drug Value Chain
    Figure 76. Gastric Antisecretory Drug Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed